SEBI Bars Seven Family Members in Social Media PumpandDump Case Alleges 2025 Crore Illegal Gains Argus Research Projects LongTerm Growth Potential for Applied Materials AMAT Japan Stocks Surge to AllTime High on Iran Deal Optimism Jim Cramer Advises Investors to Focus on Future Potential Rather Than Past Gains in AI Stocks Should a 62YearOld Claim Social Security Now and Switch to Survivors Benefit at 67 A BreakEven Analysis London Stock Exchange Group Reports Income Growth Driven by Tradewebs Strong Performance FFAI Q1 2026 Earnings Narrowed Losses Beat Estimates but No Revenue Reported and Stock Drops 981 BIPC Q1 2026 Earnings Significant EPS Miss Amid Market Optimism Sangoma Q1 2026 Earnings EPS Miss Weighs on Shares as Revenue Details Remain Unclear UEC Q1 2026 Earnings NarrowerThanExpected Loss as Uranium Developer Advances Projects Palantir Q1 2026 Earnings EPS Surpasses Estimates Revenue Details Unavailable Stock Edges Lower HFWA Q1 2026 Earnings EPS Surpasses Estimates by 343 as Stock Edges Higher Pinterest PINS Holds Steady Near Support Analyzing the Slight Uptick AngloGold Ashanti AU Slips 145 Gold Miner Hovers Between Key Support and Resistance The9 Limited NCTY Faces Selling Pressure Tests Key Support Near 502 Tenon Medical TNON Minor Uptick as Stock Holds Near Key Support at 067 ReposiTrak Inc TRAK Edges Higher Navigating Resistance at 1062 Amid Steady Volume NVIDIA Releases First Quarter Fiscal 2027 Results AI Demand Signals Under Scrutiny Ovintiv Inc OVV Q1 2026 Earnings EPS Beats Estimates Amid Solid Execution TriMas Corporation TRS Holds Gains Near Resistance After 26 Rally DoubleDown Interactive DDI Q1 2026 Earnings EPS Surges Past Expectations Stock Edges Lower EXK Q1 2026 Earnings Strong Earnings Beat Propels Silver Producer Despite Tepid Market Reception RILYT Q1 2024 Earnings Negative EPS and Revenue Omission Signal Challenges Under Armour UAA Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite Loss NEM Q1 2026 Earnings Strong EPS Beat but Shares Slide 289 CENT Q1 2026 Earnings EPS Surprises to the Upside Stock Moves Higher PRLD Q1 2026 Earnings Narrower Loss Than Anticipated as Clinical Pipeline Advances